Analysis of Biomarkers and Marginal Bone Loss in Platform-Switched and Nonplatform-Switched Implants: A Randomized Clinical Trial

Table 5

Changes in PICF biomarker levels for both groups.

	Difference	(§)
RANKL PS	ng/ml	0.001
RANKL NPS	ng/ml	0.001
P (¥)	0.973
OPG PS	ng/ml	0.001
OPG NPS	ng/ml	0.001
P (¥)	0.364
RANKL/OPG PS		0.932
RANKL/OPG NPS		0.302
P (¥)	0.42
IL-1β PS	pg/ml	0.001
IL-1β NPS	pg/ml	0.001
P (¥)	0.506
MCP-1 PS	pg/ml	0.034
MCP-1 NPS	pg/ml	0.001
P (¥)	0.044

Comparison of the change in the values from to in the groups was performed by using paired sample -test §, , ; comparison of the change in the values ratio from to between the groups was performed by using Student’s -test ¥, .